Literature DB >> 26276263

Mast cells infiltrate pancreatic islets in human type 1 diabetes.

Luisa Martino1, Matilde Masini1, Marco Bugliani2, Lorella Marselli2, Mara Suleiman2, Ugo Boggi1, Tatiane C Nogueira3, Franco Filipponi1, Margherita Occhipinti2, Daniela Campani1, Francesco Dotta4, Farooq Syed2, Decio L Eizirik3, Piero Marchetti2, Vincenzo De Tata5.   

Abstract

AIMS/HYPOTHESIS: Beta cell destruction in human type 1 diabetes occurs through the interplay of genetic and environmental factors, and is mediated by immune cell infiltration of pancreatic islets. In this study, we explored the role of mast cells as an additional agent in the pathogenesis of type 1 diabetes insulitis.
METHODS: Pancreatic tissue from donors without diabetes and with type 1 and 2 diabetes was studied using different microscopy techniques to identify islet-infiltrating cells. The direct effects of histamine exposure on isolated human islets and INS-1E cells were assessed using cell-survival studies and molecular mechanisms.
RESULTS: A larger number of mast cells were found to infiltrate pancreatic islets in samples from donors with type 1 diabetes, compared with those from donors without diabetes or with type 2 diabetes. Evidence of mast cell degranulation was observed, and the extent of the infiltration correlated with beta cell damage. Histamine, an amine that is found at high levels in mast cells, directly contributed to beta cell death in isolated human islets and INS-1E cells via a caspase-independent pathway. CONCLUSIONS/
INTERPRETATION: These findings suggest that mast cells might be responsible, at least in part, for immune-mediated beta cell alterations in human type 1 diabetes. If this is the case, inhibition of mast cell activation and degranulation might act to protect beta cells in individuals with type 1 diabetes.

Entities:  

Keywords:  Histamine; Human islets; Insulitis; Mast cells; Type 1 diabetes; Type 2 diabetes

Mesh:

Year:  2015        PMID: 26276263     DOI: 10.1007/s00125-015-3734-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.

Authors:  P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

Review 2.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

3.  Role of mast cells in skin tag development: an immunohistochemical study.

Authors:  Asmaa Gaber Abdou; Alaa Hassan Maraee; Azza Gaber Antar; Shimaa Fareed
Journal:  Anal Quant Cytopathol Histpathol       Date:  2014-08

4.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

5.  Beta-cell replication is increased in donor organs from young patients after prolonged life support.

Authors:  Peter In't Veld; Neelke De Munck; Kristien Van Belle; Nicole Buelens; Zhidong Ling; Ilse Weets; Patrick Haentjens; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

6.  Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E.

Authors:  Simona Piaggi; Michela Novelli; Luisa Martino; Matilde Masini; Chiara Raggi; Enrico Orciuolo; Pellegrino Masiello; Alessandro Casini; Vincenzo De Tata
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-06       Impact factor: 4.219

7.  The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.

Authors:  P Marchetti; M Bugliani; R Lupi; L Marselli; M Masini; U Boggi; F Filipponi; G C Weir; D L Eizirik; M Cnop
Journal:  Diabetologia       Date:  2007-09-30       Impact factor: 10.122

Review 8.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

9.  Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth?

Authors:  Mark A Atkinson
Journal:  Diabetes       Date:  2014-11       Impact factor: 9.461

10.  GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.

Authors:  Tatiane C Nogueira; Flavia M Paula; Olatz Villate; Maikel L Colli; Rodrigo F Moura; Daniel A Cunha; Lorella Marselli; Piero Marchetti; Miriam Cnop; Cécile Julier; Decio L Eizirik
Journal:  PLoS Genet       Date:  2013-05-30       Impact factor: 5.917

View more
  20 in total

Review 1.  Islet inflammation in type 2 diabetes and physiology.

Authors:  Kosei Eguchi; Ryozo Nagai
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

Review 3.  Islet inflammation in type 2 diabetes.

Authors:  Piero Marchetti
Journal:  Diabetologia       Date:  2016-02-19       Impact factor: 10.122

Review 4.  Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  Daniel Elieh-Ali-Komi; Yonghao Cao
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 5.  Inflammation in obesity, diabetes, and related disorders.

Authors:  Theresa V Rohm; Daniel T Meier; Jerrold M Olefsky; Marc Y Donath
Journal:  Immunity       Date:  2022-01-11       Impact factor: 31.745

Review 6.  [Insulitis in type 1 diabetes].

Authors:  P In't Veld; G Klöppel
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

Review 7.  Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.

Authors:  Joyceline Cuenco; Elise Dalmas
Journal:  Handb Exp Pharmacol       Date:  2022

8.  Co-localization of acinar markers and insulin in pancreatic cells of subjects with type 2 diabetes.

Authors:  Matilde Masini; Lorella Marselli; Eddy Himpe; Luisa Martino; Marco Bugliani; Mara Suleiman; Ugo Boggi; Franco Filipponi; Margherita Occhipinti; Luc Bouwens; Vincenzo De Tata; Piero Marchetti
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

9.  Expression and functional assessment of candidate type 2 diabetes susceptibility genes identify four new genes contributing to human insulin secretion.

Authors:  Fatou K Ndiaye; Ana Ortalli; Mickaël Canouil; Marlène Huyvaert; Clara Salazar-Cardozo; Cécile Lecoeur; Marie Verbanck; Valérie Pawlowski; Raphaël Boutry; Emmanuelle Durand; Iandry Rabearivelo; Olivier Sand; Lorella Marselli; Julie Kerr-Conte; Vikash Chandra; Raphaël Scharfmann; Odile Poulain-Godefroy; Piero Marchetti; François Pattou; Amar Abderrahmani; Philippe Froguel; Amélie Bonnefond
Journal:  Mol Metab       Date:  2017-04-08       Impact factor: 7.422

Review 10.  Organisation of the human pancreas in health and in diabetes.

Authors:  Mark A Atkinson; Martha Campbell-Thompson; Irina Kusmartseva; Klaus H Kaestner
Journal:  Diabetologia       Date:  2020-09-07       Impact factor: 10.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.